Ovarian hyperstimulation syndrome: an endocrinopathy?
- 1 June 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 13 (3) , 329-333
- https://doi.org/10.1097/00001703-200106000-00014
Abstract
Ovarian hyperstimulation syndrome remains a significant but incompletely understood complication of ovarian stimulation. Evidence has accumulated regarding a role for various cytokines, in particular vascular endothelial growth factor, in its occurrence. However, the pathogenesis of ovarian hyperstimulation syndrome is likely to be complex and may involve a network of interacting cytokines and endocrine factors. Recent studies suggest links between specific cytokines and specific functional abnormalities in severe ovarian hyperstimulation syndrome. Two clinical forms of ovarian hyperstimulation syndrome may be distinguished, based on time of onset, with implications for the prediction and prevention of ovarian hyperstimulation syndrome in clinical practice.Keywords
This publication has 28 references indexed in Scilit:
- Role of vascular endothelial growth factor in ovarian physiology and pathologyFertility and Sterility, 2000
- The ovarian hyperstimulation syndromeFertility and Sterility, 2000
- Distinction between early and late ovarian hyperstimulation syndromeFertility and Sterility, 2000
- Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndromeFertility and Sterility, 1999
- Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.Journal of Clinical Investigation, 1998
- The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndromeJournal of Molecular Endocrinology, 1998
- Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.Human Reproduction, 1998
- Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndromeFertility and Sterility, 1997
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994
- The role of luteal phase support in infertility treatment: a meta-analysis of randomized trialsFertility and Sterility, 1994